Table 2 Lipid profiles and AIP of the no-HIV, AHI and CHI participants

TG (mmol/L)

1.17 (0.76–1.67)

1.11 (0.89–1.52)

1.06 (0.79–1.42)

TC (mmol/L)

4.49 ± 0.91^a

3.90 ± 0.73

3.72 ± 0.74

HDL-C (mmol/L)

1.19 ± 0.29^a

1.00 ± 0.25

1.01 ± 0.30

LDL-C (mmol/L)

2.75 ± 0.78^a

2.11 ± 0.57

2.22 ± 0.58

TC/HDL-C

3.79 (3.18–4.54)

3.95 (3.45–4.57)

3.67 (3.19–4.29)

Hypertriglyceridemia, n (%)

23 (23.0)

17 (15.5)

22 (20.0)

Hypercholesterolemia, n (%)

21 (21.0)^a

7 (6.4)

3 (2.7)

Low HDL-C, n (%)

17 (17.0)^a

37 (33.6)

44 (40.0)

High LDL-C, n (%)

16 (16.0)^a

2 (1.8)

2 (1.8)

High TC/HDL-C ratio, n (%)

16 (16.0)

16 (14.5)

15 (13.6)

Dyslipidemia, n (%)

44 (44.0)

51 (46.4)

52 (47.3)

AIP

−0.04 (−0.21–0.22)

0.08 (−0.05–0.20)^b

0.03 (−0.17–0.23)

AIP > 0.1, n (%)

38 (38.0)

51 (46.4)

48 (43.6)